Vaccitech PLC - ESG Rating & Company Profile powered by AI
This page is a free Sustainability assessment covering Vaccitech PLC. Browse to the end of the webpage for potential risks for Vaccitech PLC based on sector, location and size. The assessment of Vaccitech PLC uses information from across the web as well as from public filings by Vaccitech PLC.
Vaccitech PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Vaccitech PLC | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vaccitech PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vaccitech PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Vaccitech PLC report the average age of the workforce?
Sign up for free to unlockDoes Vaccitech PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vaccitech PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vaccitech PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Vaccitech PLC offer flexible work?
Sign up for free to unlockDoes Vaccitech PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vaccitech PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vaccitech PLC conduct supply chain audits?
Sign up for free to unlockDoes Vaccitech PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vaccitech PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vaccitech PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vaccitech PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vaccitech PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vaccitech PLC disclose water use targets?
Sign up for free to unlockDoes Vaccitech PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Vaccitech PLC have a product recall in the last two years?
Sign up for free to unlockDoes Vaccitech PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Vaccitech PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vaccitech PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vaccitech PLC disclose parental leave metrics?
Sign up for free to unlockDoes Vaccitech PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vaccitech PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vaccitech PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vaccitech PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vaccitech PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vaccitech PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vaccitech PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Vaccitech PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vaccitech PLC disclose its waste policy?
Sign up for free to unlockDoes Vaccitech PLC report according to TCFD requirements?
Sign up for free to unlockDoes Vaccitech PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vaccitech PLC disclose energy use targets?
Sign up for free to unlockDoes Vaccitech PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vaccitech PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vaccitech PLC
These potential risks are based on the size, segment and geographies of the company.
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.